Luda Diatchenko

Last updated

Luda Diatchenko is an academic and researcher at McGill University in Quebec, Canada, with a research focus on pain in humans. [1] In 2023, she was inducted as a Fellow of the Royal Society of Canada. [2] Her work has covered genetics and pharmaceuticals, including finding that anti-inflammatory drugs can contribute to the development of chronic pain. [3] She has previously worked at the University of North Carolina at Chapel Hill. [4]

Diatchenko holds appointments as the Canada Excellence Research Chair (CERC) in Human Pain Genetics, [4] the Pfizer Canada Professor in Pain Research, [2] and a membership in the Canadian Academy of Health Sciences. In 2019 she received the title of Honorary Skou Professor from Aarhus University. [5]

Related Research Articles

<span class="mw-page-title-main">Ketoprofen</span> NSAID analgesic medication

Ketoprofen is one of the propionic acid class of nonsteroidal anti-inflammatory drugs (NSAID) with analgesic and antipyretic effects. It acts by inhibiting the body's production of prostaglandin.

<span class="mw-page-title-main">Nonsteroidal anti-inflammatory drug</span> Class of therapeutic drug for relieving pain and inflammation

Non-steroidal anti-inflammatory drugs (NSAID) are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever, and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.

<span class="mw-page-title-main">Paracetamol</span> Common medication for pain and fever

Paracetamol (acetaminophen) is a non-opioid analgesic and antipyretic agent used to treat fever and mild to moderate pain. It is a widely used over the counter medication. Common brand names include Tylenol and Panadol.

<span class="mw-page-title-main">Ibuprofen</span> Medication used for treating pain, fever, and inflammation

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that is used to relieve pain, fever, and inflammation. This includes painful menstrual periods, migraines, and rheumatoid arthritis. It may also be used to close a patent ductus arteriosus in a premature baby. It can be used orally or intravenously. It typically begins working within an hour.

<span class="mw-page-title-main">Diclofenac</span> Nonsteroidal anti-inflammatory drug

Diclofenac, sold under the brand name Voltaren, among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. It is taken by mouth or rectally in a suppository, used by injection, or applied to the skin. Improvements in pain last for as much as eight hours. It is also available in combination with misoprostol in an effort to decrease stomach problems.

<span class="mw-page-title-main">Ronald Melzack</span> Canadian psychologist

Ronald Melzack was a Canadian psychologist and professor of psychology at McGill University. In 1965, he and Patrick David Wall revolutionized pain research by introducing the gate control theory of pain. In 1968, Melzack published an extension of the gate control theory, in which he asserted that pain is subjective and multidimensional because several parts of the brain contribute to it at the same time. During the mid-1970s, he developed the McGill Pain Questionnaire and became a founding member of the International Association for the Study of Pain. He also became the founding editor of Wall & Melzack's Textbook of Pain.

<span class="mw-page-title-main">Naproxen</span> Nonsteroidal anti-inflammatory drug (NSAID) used to treat pain

Naproxen, sold under the brand name Aleve among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain, menstrual cramps, and inflammatory diseases such as rheumatoid arthritis, gout and fever. It is taken orally. It is available in immediate and delayed release formulations. Onset of effects is within an hour and lasts for up to twelve hours.

Charles Robert Scriver was a Canadian pediatrician and biochemical geneticist. His work focused on inborn errors of metabolism and led in establishing a Canada-wide newborn metabolic screening program.

<span class="mw-page-title-main">Meloxicam</span> Nonsteroidal anti-inflammatory drug (NSAID)

Meloxicam, sold under the brand name Mobic among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It is used by mouth or by injection into a vein. It is recommended that it be used for as short a period as possible and at a low dose.

A number of professional degrees in dentistry are offered by dental schools in various countries around the world.

<span class="mw-page-title-main">Bartha Knoppers</span> Canadian lawyer and scientist

Bartha Maria Knoppers, OC OQ is a Canadian law Professor and an expert on the ethical aspects of genetics, genomics and biotechnology.

<span class="mw-page-title-main">McGill University Faculty of Medicine and Health Sciences</span> Medical school in Canada

The Faculty of Medicine and Health Sciences is one of the constituent faculties of McGill University. It was established in 1829 after the Montreal Medical Institution was incorporated into McGill College as the college's first faculty; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833.

An oral medicine or stomatology doctor/dentist has received additional specialized training and experience in the diagnosis and management of oral mucosal abnormalities including oral cancer, salivary gland disorders, temporomandibular disorders and facial pain, taste and smell disorders; and recognition of the oral manifestations of systemic and infectious diseases. It lies at the interface between medicine and dentistry. An oral medicine doctor is trained to diagnose and manage patients with disorders of the orofacial region.

<span class="mw-page-title-main">McGill University Faculty of Dentistry</span>

The Faculty of Dental Medicine and Oral Health Sciences is one of the constituent faculties of McGill University. It became established as a constituent of McGill University in 1904 as the McGill Dental School, a department in the McGill University Faculty of Medicine until becoming its own faculty in 1920. In 2022, the Faculty of Dentistry was renamed as the Faculty of Dental Medicine and Oral Health Sciences to reflect the diversity of research conducted in the Faculty that goes beyond the dental chair. The Faculty is closely affiliated with the Montreal General Hospital, Jewish General Hospital, Montreal Children's Hospital, and McGill University Faculty of Medicine.

<span class="mw-page-title-main">Sydney Dental School</span>

The University of Sydney School of Dentistry also known as Sydney Dental School is Australia's first dental school and a constituent body of the University of Sydney, Australia.

<span class="mw-page-title-main">Michael R. Hayden</span>

Michael R. Hayden, is a Killam Professor of Medical Genetics at the University of British Columbia, the highest honour UBC can confer on any faculty member. Only four such awards have ever been conferred in the Faculty of Medicine. Dr. Hayden is also Canada Research Chair in Human Genetics and Molecular Medicine. Hayden is best known for his research in Huntington disease (HD).

<span class="mw-page-title-main">Grapiprant</span> NSAID anti-inflammatory veterinary drug

Grapiprant, sold under the brand name Galliprant, is a small molecule drug that belongs in the piprant class. This analgesic and anti-inflammatory drug is primarily used as a pain relief for mild to moderate inflammation related to osteoarthritis in dogs. Grapiprant has been approved by the FDA's Center for Veterinary Medicine and was categorized as a non-cyclooxygenase inhibiting non-steroidal anti-inflammatory drug (NSAID) in March 2016.

<span class="mw-page-title-main">Niki Moutsopoulos</span> Greek periodontist and immunologist

Niki M. Moutsopoulos is a Greek periodontist and immunologist. She is a senior investigator in the oral immunity and infection section at the National Institute of Dental and Craniofacial Research. Moutsopoulos specializes in oral immunology and periodontitis. Her research program focuses on host-microbial interactions that can drive chronic inflammatory responses and tissue destruction in the oral cavity.

Elham Emami is an Iranian-Canadian clinician scientist. She is the dean of McGill University Dental Medicine and Oral Health Sciences. Born and raised in Iran, Emami moved to Canada in 2002 to pursue her PhD and MSc at the Université de Montréal.

References

  1. "Canadian study offers important clue to why some back pain becomes chronic". CBC News .
  2. 1 2 "Luda Diatchenko named a Fellow of the Royal Society of Canada". Faculty of Dental Medicine and Oral Health Sciences. Retrieved 2024-04-03.
  3. Admin (2022-07-26). "McGill study finds anti-inflammatory drugs may lead to chronic pain". The Tribune. Retrieved 2024-04-03.
  4. 1 2 Mcdevitt, Neale (2013-09-25). "Dr. Luda Diatchenko awarded more than $10 million in federal funding as CERC in Human Pain Genetics". McGill Reporter. Retrieved 2024-04-03.
  5. "Dr. Diatchenko Receives Honorary Award". Faculty of Dental Medicine and Oral Health Sciences. Retrieved 2024-04-03.